{"id":191377,"date":"2025-11-20T20:46:10","date_gmt":"2025-11-20T20:46:10","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/191377\/"},"modified":"2025-11-20T20:46:10","modified_gmt":"2025-11-20T20:46:10","slug":"sahpra-on-the-sale-of-fake-glp-1-products","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/191377\/","title":{"rendered":"SAHPRA on the sale of fake GLP-1 products"},"content":{"rendered":"<p>GLP-1 medications are used to treat Type 2 diabetes and obesity, mostly administered as injections. The most well-known one is probably Ozempic, which has become commonly used for weight loss.<\/p>\n<p>But the high cost has created a market for unregistered and unsafe versions of these medications, largely sold on social media platforms. These products are not tested or regulated in South Africa.<\/p>\n<p>Regulatory compliance officer at the South African Health Products Regulatory Authority (SAHPRA), Coceka Ntlantla said: &#8220;The products come from China, and some buyers don&#8217;t even receive the products in the first place.&#8221;<\/p>\n<p>As for what specific ingredients these fake substitutes contain, Ntlantla said that testing was currently underway, but that they can &#8220;have severe adverse effects&#8221;.<\/p>\n<p>These drugs are also supposed to be kept refrigerated, which does not happen if they are sent from overseas.<\/p>\n<p>Ntlantla further warned that one needs a prescription from a licensed health professional for this type of medication, which is categorised as S4, and to be monitored by a doctor while on the treatment.<\/p>\n<p>&#8220;Anything above S3 is supposed to be scripted on a prescription, and then you go to a registered pharmacy.&#8221;<\/p>\n<p>SAHPRA has also become aware of companies and individuals illegally marketing GLP-1 products online, and falsely claiming to be affiliated with or authorised by SAHPRA and some of South Africa\u2019s major retail pharmacies. Find out more from <a rel=\"noopener nofollow\" href=\"https:\/\/www.sahpra.org.za\/news-and-updates\/sahpra-warns-the-public-about-glp-1-products-sold-through-social-media-platforms\/\" target=\"_blank\">SAHPRA here<\/a>.<\/p>\n<p><strong>To listen to Ntlantla in conversation with <a href=\"https:\/\/www.primediaplus.com\/capetalk\/views-and-news-with-clarence-ford\/\" rel=\"nofollow noopener\" target=\"_blank\">CapeTalk&#8217;s Clarence Ford<\/a>, click below:<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"GLP-1 medications are used to treat Type 2 diabetes and obesity, mostly administered as injections. The most well-known&hellip;\n","protected":false},"author":2,"featured_media":191378,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[274],"tags":[18,61303,61304,61307,61306,61305,135,19,17,11,462,5,1829,61310,61309,61308],"class_list":{"0":"post-191377","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-eire","9":"tag-ewn","10":"tag-ewn-news","11":"tag-ewn-south-africa","12":"tag-eye-witness-news","13":"tag-eyewitness-news","14":"tag-health","15":"tag-ie","16":"tag-ireland","17":"tag-latest-news","18":"tag-medication","19":"tag-news","20":"tag-news-today","21":"tag-prime-media-plus","22":"tag-primedia-plus","23":"tag-primedia"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115583987431816486","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/191377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=191377"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/191377\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/191378"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=191377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=191377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=191377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}